Increase in prevalence of autoimmune diseases, rise in technological advancements, and rise in awareness about early diagnosis are the major factors which drive the global market growth. Increasing ...

According to industry analysis, increasing cases of rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, celiac disease, and other chronic autoimmune conditions are driving testing ...

Medically reviewed by Stella Bard, MD Key Takeaways A Sjögren's antibody test looks for anti-SS-A and anti-SS-B antibodies to help diagnose Sjögren's disease. Not everyone with Sjögren's has these ...

Exagen Inc. has reached a major milestone by completing its 1,000,000th AVISE CTD test, a diagnostic tool for autoimmune and connective tissue diseases. This achievement highlights the company’s ...

A research team from the University of Oklahoma Health Sciences Center, led by Madeleine Cunningham, Ph.D., in conjunction with the National Institute of Mental Health (NIMH), has developed the ...

Add Yahoo as a preferred source to see more of our stories on Google. Autoimmune diseases are on the rise. It’s not just a hunch—autoimmune diseases are rising sharply, and the numbers are too ...

Exagen delivered record first-quarter revenue and improved adjusted EBITDA metrics as the autoimmune diagnostics company continued expanding adoption of its AVISE CTD testing platform. ・Exagen Inc.

Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, has joined with 40 other centers in the U.S. and Europe as a site in one of the first clinical trials ...

The test that they developed allows detection at the earliest signs of the immune system assault against the pancreas, which is an advantage because most patients being tested for type 1 diabetes are ...

Uniquely identified ~25% of the SLE patients who would otherwise be missed by conventional markers Demonstrated superior diagnostic accuracy compared with conventional testing, supporting earlier, ...

BURLINGTON, N.C.--(BUSINESS WIRE)-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has entered into a definitive agreement to acquire select operating assets and ...